Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
20
Number of overlapping holdings
32.8%
% of BBP's 65 holdings also in WDNA
22.7%
% of WDNA's 91 holdings also in BBP
Overlap by Weight
Sector Drift (BBP minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBP |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
SAREPTA THERAPEUTICS INC | 1.7% | 1.7% | 1.7% |
|
IOVANCE BIOTHERAPEUTICS INC | 1.6% | 1.7% | 1.6% |
|
BLUEPRINT MEDICINES CORP. | 1.5% | 2.6% | 1.5% |
|
VERTEX PHARMACEUTICALS INC | 1.5% | 1.6% | 1.5% |
|
UNITED THERAPEUTICS CORP | 1.7% | 1.5% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
BBP Overweight Relative to WDNA
|
MIRUM PHARMACEUTICALS, INC. | 2.4% |
|
TRAVERE THERAPEUTICS, INC. | 2.0% |
|
LIGAND PHARMACEUTICALS-CL B | 1.9% |
|
LEXICON PHARMACEUTICALS, INC. | 1.9% |
|
LEGEND BIOTECH CORPORATION SPONSORED | 1.9% |
|
ACADIA PHARMACEUTICALS INC | 1.9% |
|
BIOCRYST PHARMACEUTICALS INC | 1.8% |
|
DAY ONE BIOPHARMACEUTICALS, INC. | 1.8% |
|
TG THERAPEUTICS INC | 1.8% |
|
ADMA BIOLOGICS, INC. | 1.8% |
BBP Underweight Relative to WDNA
|
TWIST BIOSCIENCE CORP. | -4.3% |
 |
NOVOZYMES A/S-B SHARES | -2.7% |
|
FATE THERAPEUTICS INC | -2.2% |
|
NATERA INC | -2.2% |
|
VERICEL CORPORATION | -2.1% |
|
ELI LILLY & CO | -2.1% |
|
MYRIAD GENETICS INC | -1.4% |
|
DANAHER CORP | -1.4% |
|
BEAM THERAPEUTICS, INC. | -1.4% |
|
STOKE THERAPEUTICS, INC. | -1.4% |